SCHEMBL7232176

SCHEMBL7232176

Nc1cccc(-c2cc([N+](=O)[O-])ccn2)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.57
ASIC3 Q9UHC3 2/20 0.47
PLK1 P53350 1/20 0.46
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
BCHE P06276 1/20 0.45
ACHE P22303 1/20 0.45
IDO1 P14902 1/20 0.44
PDE4D Q08499 2/20 0.44
KEAP1 Q14145 2/20 0.44
NFE2L2 Q16236 2/20 0.44
LMNA P02545 3/20 0.43
MGAM O43451 1/20 0.43
GAA P10253 1/20 0.43
SI P14410 1/20 0.43
PKM P14618 1/20 0.43
MGAM2 Q2M2H8 1/20 0.43
MAPT P10636 3/20 0.43
GRM5 P41594 1/20 0.43
ROCK1 Q13464 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2026676 0.79 ALDH1A1 (0.78) ALDH1A1NPC1RAB9AACHEIDO1
SCHEMBL30469275 0.79 ALDH1A1 (0.78) ALDH1A1NPC1RAB9AACHEIDO1
SCHEMBL3143591 0.78 KEAP1 (0.57) ALDH1A1PLK1NPC1RAB9ABCHE
SCHEMBL546381 0.78 ABL1 (0.59) RAB9ABCHEACHEPDE4DLMNA
SCHEMBL826630 0.78 TSHR (0.50) ALDH1A1NPC1RAB9AACHELMNA
SCHEMBL28844239 0.78 PLK1 (0.47) ALDH1A1ASIC3PLK1NPC1RAB9A
Water SCHEMBL29134001 0.77 ALDH1A1 (0.75) ALDH1A1NPC1RAB9AACHEIDO1
SCHEMBL7086073 0.77 ALDH1A1 (0.46) ALDH1A1RAB9ALMNAGAAMAPT
SCHEMBL27491688 0.76 ASIC3 (0.56) ALDH1A1ASIC3NPC1RAB9ALMNA
SCHEMBL4734622 0.76 ABL1 (0.76) PLK1NPC1RAB9AROCK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6521643-B1 Prevention and/or treatment of nitric oxide synthasey medi-ated diseases such as adult respiratory distress syndrome, myocarditis, synovitis, septic shock, diabetes, ulcerative colitis, cerebral infarction, osteoarthritis FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-02-18 US disclosed
EP-1157022-A1 PYRIDINE COMPOUNDS AND THEIR PHARMACEUTICAL USE FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-11-28 EP disclosed
WO-2000049015-A1 PYRIDINE COMPOUNDS AND THEIR PHARMACEUTICAL USE FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-08-24 WO disclosed